Home » Topics » Regulatory » Patents

Patents
RSS

Janssen Pharmaceutica synthesizes new CDK7 inhibitors

July 21, 2022

Wuhan Yuxiang Pharmaceutical Technology identifies SOS1/KRAS interaction inhibitors

July 21, 2022

Korea Institute of Science and Technology divulges TGF-beta inhibitors

July 21, 2022

Incyte patents new JAK2 inhibitors

July 21, 2022

Tsinghua University synthesizes new NAMPT enzyme activators

July 20, 2022

Galecto Biotech identifies new LGALS inhibitors

July 20, 2022

Praxis Precision Medicines discloses KCNT1 inhibitors

July 20, 2022

Korean investigators divulge new EGFR inhibitors

July 20, 2022

Jiangsu Hengrui Medicine patents PTPN11 inhibitors

July 20, 2022

Chinese researchers synthesize new vasopressin receptor antagonists

July 19, 2022

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...